AS-IV enhances the antitumor effects of propofol in NSCLC cells by inhibiting autophagy

Non-small cell lung cancer (NSCLC) is one of the most lethal malignant tumors. It has been shown that the general anesthetic agents, propofol and astragaloside IV (AS-IV) both exert antitumor effects in NSCLC. However, the effects of the combination of propofol with AS-IV in NSCLC remain unclear. Ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jintao, Chen, Long, Zhang, Jialing, Luo, Xiaopan, Tan, Yingyi, Qian, Shaojie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523104/
https://www.ncbi.nlm.nih.gov/pubmed/37771421
http://dx.doi.org/10.1515/med-2023-0799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10523104/
https://www.ncbi.nlm.nih.gov/pubmed/37771421
http://dx.doi.org/10.1515/med-2023-0799

Ejemplares similares